A detailed history of Pnc Financial Services Group, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 162 shares of AUPH stock, worth $1,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
162
Previous 162 -0.0%
Holding current value
$1,334
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$4.81 - $5.78 $779 - $936
162 New
162 $0
Q4 2023

Feb 09, 2024

BUY
$7.13 - $9.49 $57 - $75
8 New
8 $0
Q3 2022

Nov 10, 2022

BUY
$6.66 - $12.39 $173 - $322
26 Added 1.11%
2,370 $17,000
Q2 2022

Aug 12, 2022

BUY
$8.95 - $12.8 $1,109 - $1,587
124 Added 5.59%
2,344 $23,000
Q1 2022

May 12, 2022

SELL
$10.05 - $22.48 $312,052 - $698,004
-31,050 Reduced 93.33%
2,220 $27,000
Q4 2021

Feb 11, 2022

BUY
$17.78 - $33.08 $549,562 - $1.02 Million
30,909 Added 1309.15%
33,270 $760,000
Q3 2021

Nov 05, 2021

SELL
$10.93 - $23.55 $546,183 - $1.18 Million
-49,971 Reduced 95.49%
2,361 $52,000
Q2 2021

Aug 06, 2021

SELL
$10.0 - $14.52 $38,810 - $56,352
-3,881 Reduced 6.9%
52,332 $678,000
Q1 2021

May 07, 2021

BUY
$12.3 - $18.73 $642,219 - $977,949
52,213 Added 1305.33%
56,213 $729,000
Q4 2020

Feb 12, 2021

SELL
$12.94 - $16.05 $323 - $401
-25 Reduced 0.62%
4,000 $55,000
Q3 2020

Nov 06, 2020

BUY
$13.19 - $16.66 $52,760 - $66,640
4,000 Added 16000.0%
4,025 $59,000
Q4 2019

Feb 07, 2020

BUY
$3.88 - $21.42 $97 - $535
25 New
25 $0
Q4 2018

Feb 08, 2019

SELL
$5.08 - $6.83 $15,240 - $20,490
-3,000 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$4.85 - $5.99 $14,549 - $17,970
3,000 New
3,000 $0

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.17B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.